Aethlon Medical Inc AEMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AEMD is a good fit for your portfolio.
News
-
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
-
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
-
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Trading Information
- Previous Close Price
- $1.50
- Day Range
- $1.33–1.50
- 52-Week Range
- $1.33–5.00
- Bid/Ask
- $1.36 / $1.44
- Market Cap
- $3.58 Mil
- Volume/Avg
- 19,769 / 8,449
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.76
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 15
- Website
- https://www.aethlonmedical.com
Valuation
|
Metric
|
AEMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.46 |
Price/Sales | 5.76 |
Price/Cash Flow | — |
Price/Earnings
AEMD
Financial Strength
|
Metric
|
AEMD
|
|---|---|
Quick Ratio | 3.80 |
Current Ratio | 3.93 |
Interest Coverage | — |
Quick Ratio
AEMD
Profitability
|
Metric
|
AEMD
|
|---|---|
Return on Assets (Normalized) | −70.56% |
Return on Equity (Normalized) | −86.06% |
Return on Invested Capital (Normalized) | −81.68% |
Return on Assets
AEMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rbysfyhx | Zfbhjd | $185.4 Bil | |
SYK
| Stryker Corp | Dwzhkzggg | Wyylh | $127.7 Bil | |
BSX
| Boston Scientific Corp | Dtllkzdqc | Ytcwrfh | $107.6 Bil | |
MDT
| Medtronic PLC | Jttbjbh | Vrgrslz | $105.9 Bil | |
DXCM
| DexCom Inc | Rwzglckgj | Rgz | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Vnkgzxjz | Qvbgsyq | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mkbyygkvm | Hrpp | $24.6 Bil | |
ALGN
| Align Technology Inc | Tfytlvzm | Rjqhbr | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Gwbsfhqz | Wkngvb | $18.7 Bil | |
PODD
| Insulet Corp | Lgpxbhwytt | Wllmdd | $11.6 Bil |